Paediatric Posterior Reversible Encephalopathy Syndrome (PRES) Induced by Ibuprofen Intake: A Case Report.
Bargiacchi Giuditta G, De Marco Oriana O, Petruzzelli Luigi Annicchiarico LA, Tucci Celeste C et al.
Therabel · PTGS1 · 小分子
ibuprofen 是一种小分子,由Therabel研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。
| 商品名 | ibuprofen, Diffutab |
| 公司 | Therabel |
| 药物类别 | 小分子 |
| 分子靶点 | PTGS1, PTGS2 |
| 给药途径 | Oral (PO) |
| 状态 | Approved |
ibuprofen 作用于 2 个分子靶点:
| PTGS1 | prostaglandin-endoperoxide synthase 1 (COX3, PCOX1) |
| PTGS2 | prostaglandin-endoperoxide synthase 2 (GRIPGHS, hCox-2) |
ibuprofen 针对 1 个适应症,涉及 1 个治疗领域。
| 治疗领域 | 疾病/病症 | 分期 |
|---|---|---|
| Gastrointestinal disorders | Abdominal pain | ✓ Approved |
Bargiacchi Giuditta G, De Marco Oriana O, Petruzzelli Luigi Annicchiarico LA, Tucci Celeste C et al.
Binidris Mutasim M, Shehata Menatalla M, Mahfouz Ahmed A, Abousaad Omar O et al.
Invasive meningococcal disease is a life-threatening infection that classically presents as meningitis or meningococcemia. Extra-meningeal manifestations, including pericarditis and septic arthritis, are uncommon and may complicate diagnosis, particularly in the absence of meningeal involvement. A previously healthy vaccinated man in his 50s presented with acute bilateral knee pain and swelling following a short history of fever, productive cough, fatigue, and dyspnea. Blood cultures grew Neisseria meningitidis serogroup W, whereas cerebrospinal fluid, synovial fluid, and pericardial fluid cultures remained negative. Cardiac magnetic resonance imaging demonstrated constrictive pericarditis with circumferential pericardial enhancement and pericardial effusion. The patient was successfully treated with intravenous ceftriaxone, colchicine, ibuprofen, pericardiocentesis, and bilateral knee washout, followed by oral ciprofloxacin. This case adds to the limited literature describing concurrent cardiac and musculoskeletal manifestations of invasive meningococcal disease without meningitis and shows the importance of early recognition, comprehensive investigation and multidisciplinary management of these uncommon presentations.
Kobayashi Madoka M, Kato Fumitaka F, Okada Kotaro K
The present study evaluated the applicability of time-domain NMR (TD-NMR) for detecting crystalline ibuprofen components in ibuprofen-loaded mesoporous silica. Ibuprofen-loaded mesoporous silica samples with different drug loadings were prepared, and the physical state of ibuprofen was characterized by nitrogen adsorption, powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), 13C solid-state NMR spectroscopy, and TD-NMR relaxation measurements. PXRD, DSC, and 13C solid-state NMR spectroscopy did not clearly detect crystalline ibuprofen in samples with ibuprofen loadings of 10-30%. By contrast, crystalline components were observed in samples with loadings of 40% or higher. These crystalline components were considered to originate predominantly from excess ibuprofen that crystallized outside the mesopores. In the T1 relaxation analysis using TD-NMR, IBU10-30 was mainly described by a monoexponential function, whereas IBU40-70 required a biexponential function, yielding a long T1 component associated with crystalline ibuprofen. In the T2 relaxation analysis, IBU40-70 exhibited an initial rapid decay that was described by a Gaussian function, whereas IBU10-30 showed a gradual exponential decay. The signal proportions of these NMR relaxation components increased with increasing ibuprofen loading and showed trends consistent with the apparent crystallinity estimated by DSC. These results suggest that TD-NMR, particularly T2 relaxation analysis, may serve as a complementary, nondestructive, and rapid method for evaluating the appearance and increase of crystalline ibuprofen components in mesoporous silica formulations and for monitoring changes in crystallinity.
Puri Aarti A, Pant Kamal Kishore KK, Das Diganta Bhusan DB, Srivastava Vimal Chandra VC
Organic contaminants of emerging concern (OCECs) exhibit diverse molecular structures that critically determine their environmental persistence and degradation pathways. Most photocatalysis research remains focused on catalyst design, with limited mechanistic interpretation at the molecular level. Herein, we investigate structure-reactivity-sustainability relationships in visible-light-driven photocatalytic degradation of indigo carmine (IC), tetracycline (TTC), and ibuprofen (IBU) using a recyclable TiO₂/CeO₂/g-C₃N₄ (TiCe-gCN) heterojunction photocatalyst. The ternary composite exhibited enhanced activity and stability attributed to superior charge separation. Degradation kinetics followed pseudo-first-order behavior with rate constants in the order IC (0.0397 min⁻¹) > TTC (0.0215 min⁻¹) > IBU (0.0157 min⁻¹), reflecting intrinsic molecular reactivity differences. Mechanistic interpretation was achieved by coupling LC-MS transformation product analysis with DFT-derived descriptors including condensed Fukui indices, electrostatic potential maps, and HOMO-LUMO energy gaps. The analysis revealed distinct structure-dependent degradation behaviors: IC exhibited delocalized radical susceptibility facilitating rapid oxidative bond cleavage; TTC displayed localized reactivity leading to sequential hydroxylation and ring-opening; and IBU showed localized radical accessibility at benzylic positions promoting oxidative dealkylation. This is further strengthened using EPR spin-trapping experiments, providing evidence on the charge carrier and reactive species that participate in the photocatalytic process. Beyond degradation performance, life cycle assessment (LCA) was conducted to evaluate the environmental sustainability of the TiCe-gCN system, identifying electricity consumption during catalyst synthesis as the dominant burden across all impact categories. Projected grid decarbonization could reduce global warming potential (GWP) by 54.9% by 2040, highlighting the critical role of energy infrastructure in determining the sustainability of photocatalytic water treatment.
Hersh Elliot V EV, Moore Paul A PA, Theken Katherine N KN
Because dental implant post-surgical pain is mainly driven by inflammation, nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (eg, Advil\'ae, Motrin\'ae IB) or naproxen sodium (Aleve\'ae) are logical choices to address it. These drugs are highly efficacious, non-addicting, and generally well tolerated. Dental implant patients, however, are generally older than those having their impacted third molars removed and are, therefore, likely to present with more comorbidities and drug intake, leading to potentially more adverse effects and serious adverse drug interactions. Fortunately, pain following dental implant surgery is generally milder than that of impacted third molar surgery and is amenable to low over-the-counter (OTC) dosing regimens. Administering NSAIDs immediately after surgery before the local anesthesia has worn off and then around the clock for 2 to 3 days appears to be an effective strategy at not only preventing the onset of postoperative pain, but also diminishing breakthrough pain, which is typically seen with as-needed (PRN) dosing. Implant surgeons must be able to identify those patients in whom a short course of NSAIDs can be used safely and employ dosing strategies that provide optimal analgesic efficacy while limiting untoward events. This article discusses current recommendations for postoperative pain management in dental implant patients, emphasizing the role of NSAIDs while addressing patient-specific safety considerations.
Lygidakis N N NN, Brusevold I J IJ, Manton D D, Gillam D D et al.
Molar incisor hypomineralisation (MIH) is frequently associated with hypersensitivity, dental anxiety and reduced efficacy of local anaesthesia, complicating pain control during dental treatment in children. To evaluate, based exclusively on randomised controlled trials (RCTs), the effectiveness of different local anaesthetic techniques, agents and adjunctive interventions in reducing pain during dental treatment of MIH-affected teeth in children. A systematic review was conducted following PRISMA 2020 guidelines and registered in PROSPERO (CRD420251150485). MEDLINE, Cochrane Central, ScienceDirect, SCOPUS, EBSCO, and LILACS were searched up to September 2025. Eligible studies were RCTs involving children and adolescents (6 - 18 years-of-age) with MIH, assessing pain outcomes during dental procedures. Risk of bias was assessed using the Cochrane RoB 2 tool, and certainty of evidence was evaluated using the GRADE approach. Eight RCTs were included. Low-certainty evidence suggested that intraosseous anaesthesia and 4% articaine may reduce intra-operative pain compared with conventional techniques or 2% lidocaine. Adjunctive cryotherapy and pre-emptive ibuprofen showed potential benefits, but evidence was of very low certainty and limited to single trials. Findings for photobiomodulation were inconsistent across studies. Most trials were judged to be at high risk of bias, primarily due to lack of blinding and reliance on subjective pain outcomes. Current evidence supporting specific pain management strategies for MIH-affected teeth is limited and of low certainty. Whilst 4% articaine and intraosseous anaesthesia appear promising, well-designed, adequately powered RCTs with standardised pain outcomes are required to inform robust clinical recommendations.
注册免费账户还可查看另外 9996 篇文献
免费注册查看全部文献 →